Os Therapies Incorporated
(OSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,877 | 2,802 | 2,971 | 5,534 | 1,858 |
| Receivables | N/A | N/A | 24 | N/A | N/A |
| TOTAL | $2,322 | $3,554 | $4,095 | $5,534 | $1,971 |
| Non-Current Assets | |||||
| PPE Net | 3 | 4 | 5 | 5 | 7 |
| Intangibles | 6,628 | 6,753 | 150 | 0 | 0 |
| TOTAL | $6,632 | $6,757 | $155 | $5 | $7 |
| Total Assets | $8,953 | $10,311 | $4,250 | $5,539 | $1,977 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,374 | 2,703 | 1,616 | 1,662 | 1,772 |
| Accrued Expenses | 396 | 380 | 364 | 521 | 296 |
| Other current liabilities | 375 | 375 | 1,555 | 2,347 | 505 |
| TOTAL | $4,145 | $3,458 | $3,536 | $4,627 | $2,584 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 100 | 100 | 100 | 100 | 100 |
| TOTAL | $100 | $100 | $100 | $100 | $100 |
| Total Liabilities | $4,245 | $3,558 | $3,636 | $4,727 | $2,684 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,214 | 31,892 | 28,098 | 21,664 | 21,238 |
| Common Shares | 33 | 30 | 21 | 21 | 21 |
| Retained earnings | -53,725 | -46,846 | -42,309 | -38,432 | -35,441 |
| Other shareholders' equity | 1,071 | 1,809 | 4,800 | 4,078 | 0 |
| TOTAL | $4,708 | $6,752 | $614 | $812 | $-707 |
| Total Liabilities And Equity | $8,953 | $10,310 | $4,250 | $5,539 | $1,977 |